Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia

Journal of Clinical Investigation

Volumn 108, Issue 6, 2001, Pages 851-859

  Milella, M ^a   Kornblau, S M ^a   Estrov, Z ^a   Carter, B Z ^a   Lapillonne, H ^a   Harris, D ^a   Konopleva, M ^a   Zhao, S ^a   Estey, E ^a   Andreeff, M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; INHIBITOR OF APOPTOSIS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL GROWTH; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE TARGETING; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0034823632     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12807     Document Type: Article

References (44)

1. Acute myeloid leukemia
2. Oncogenic transcription factors in the human acute leukemias
3. The fusion gene Cbfb-MYHII blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukemia
4. Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model
5. Molecular genetics of acute myeloid leukaemia
6. Signal transduction through MAP kinase cascades
7. Oncoprotein networks
8. Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: Combined role of activation of MEK, hyperexptession of extracellular signal-regulated kinase, and downregulation of a phosphatase, PACI
9. Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells
10. Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines
11. A conditionally-active form of MEK1 results in autocrine transformation of human and mouse hematopoietic cells
12. Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells
13. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia
14. Cytokine-regulated expression of survivin in myeloid leukemia
15. A synthetic inhibitor of the mitogen-activated protein kinase cascade
16. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
17. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
18. Effect of interleukin-1 beta converting enzyme inhibitor on acute myelogenous leukemia progenitor proliferation
19. Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway
20. Regulation of the cdk inhibitor p27 and its deregulation in cancer
21. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
22. Anti-apoptotic versus pro-apoptotic signal transduction: Checkpoints and stop signs along the road to death
23. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest
24. Specificity and mechanism of action of some commonly used protein kinase inhibitors
25. RAS pathways to cell cycle control and cell transformation
26. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice
27. Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27
28. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis
29. Evidence of a functional role for the cyclin-dependent kinase-inhibitor p21WAF1/CIP1/MDA6 in promoting differentianon and preventing mitochondrial dysfunction and apoptosis induced by sodium butyrate in human myelomonocytic leukemia cells (U937)
30. Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia
31. High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia
32. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Etk pathway
33. Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases
34. Expression of bcl-2-related genes in normal and AML progenitors: Changes induced by chemotherapy and retinoic acid
35. Modulation of idarubicin-induced apoptosis in human acute myeloid leukemia blasts by all-trans retinoic acid, 1,25(OH)2 vitamin D3, and granulocytemacrophage colony-stimulating factor
36. Pharmacologic interruption of the mitogen-activated extracellular-regulated kinase/mitogen-activated protein kinase signal transduction pathway: Potential role in promoting cytotoxic drug action
37. Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling
38. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogenactivated protein kinase pathway
39. PIK3CA is implicated as an oncogene in ovarian cancer
40. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
41. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation
42. Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle artest and apoptosis in tumor cells in which the pathway is constitutively activated: Up-regulation of p27Kip1
43. Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors
44. Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling